Purple Biotech (PPBT) Short Interest Ratio & Short Volume $2.78 +0.02 (+0.72%) Closing price 03/28/2025 03:58 PM EasternExtended Trading$2.78 +0.00 (+0.04%) As of 03/28/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Purple Biotech Short Interest DataPurple Biotech (PPBT) has a short interest of 51,100 shares, representing 1.94% of the float (the number of shares available for trading by the public). This marks a 5.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 247,709 shares to cover all short positions.Current Short Interest51,100 sharesPrevious Short Interest48,400 sharesChange Vs. Previous Month+5.58%Dollar Volume Sold Short$138,992.00Short Interest Ratio1.0 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares1,331,000 sharesFloat Size2,630,000 sharesShort Percent of Float1.94%Today's Trading Volume10,402 sharesAverage Trading Volume247,709 sharesToday's Volume Vs. Average4% Short Selling Purple Biotech? Sign up to receive the latest short interest report for Purple Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPPBT Short Interest Over TimePPBT Days to Cover Over TimePPBT Percentage of Float Shorted Over Time Remove Ads Purple Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202551,100 shares $138,992.00 +5.6%1.9%1 $2.72 2/28/202548,400 shares $144,232.00 -10.4%1.8%0.5 $2.98 2/15/202554,000 shares $167,400.00 -7.2%2.1%0.1 $3.10 1/31/202558,200 shares $187,986.00 -42.0%2.2%0.1 $3.23 1/15/2025100,400 shares $365,456.00 -29.1%3.9%0.1 $3.64 12/31/2024141,600 shares $664,104.00 +3.4%5.5%0.2 $4.69 12/15/2024136,900 shares $524,327.00 +94.7%5.4%0.2 $3.83 11/30/202470,300 shares $235,856.50 +103.2%2.8%0.1 $3.36 11/15/202434,600 shares $86,673.00 +77.4%1.9%0.8 $2.51 10/31/202419,500 shares $62,595.00 +8.3%1.1%0.5 $3.21 Get the Latest News and Ratings for PPBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/15/202418,000 shares $74,520.00 +37.4%1.0%0.8 $4.14 9/30/202413,100 shares $72,967.00 -33.5%0.8%0.6 $5.57 9/15/202419,700 shares $0.00 -95.3%1.2%1 $0.00 8/31/2024418,800 shares $204,793.20 +28.5%N/A1.5 $0.49 8/15/2024326,000 shares $120,587.40 -14.1%N/A1.1 $0.37 7/31/2024379,700 shares $146,458.64 -6.1%N/A1.3 $0.39 7/15/2024404,500 shares $153,790.90 -48.9%N/A1.2 $0.38 6/30/2024790,900 shares $321,896.30 +188.7%N/A2.3 $0.41 6/15/2024274,000 shares $164,674.00 -11.6%N/A1.5 $0.60 5/31/2024309,900 shares $250,244.25 +20.3%N/A1.7 $0.81 5/15/2024257,600 shares $128,800.00 -13.3%N/A1.5 $0.50 4/30/2024297,200 shares $153,860.44 +27.3%N/A2 $0.52 4/15/2024233,500 shares $132,324.45 +5.1%N/A2 $0.57 3/31/2024222,200 shares $148,874.00 -0.4%N/A2.3 $0.67 3/15/2024223,000 shares $161,641.55 -24.6%N/A2.2 $0.72 2/29/2024295,900 shares $249,857.96 -6.2%N/A2.9 $0.84 2/15/2024315,400 shares $239,672.46 -24.6%N/A3.5 $0.76 1/31/2024418,100 shares $275,946.00 -7.7%N/A5.2 $0.66 1/15/2024452,800 shares $312,432.00 -4.7%N/A4.6 $0.69 12/31/2023475,100 shares $370,578.00 -13.5%N/A4.6 $0.78 12/15/2023548,900 shares $521,455.00 +7.8%N/A5.2 $0.95 11/30/2023509,100 shares $529,464.00 -8.6%N/A5.6 $1.04 11/15/2023556,700 shares $578,968.00 -20.5%N/A6.4 $1.04 10/31/2023700,100 shares $945,135.00 -6.5%N/A8.1 $1.35 10/15/2023748,400 shares $950,468.00 +15.9%N/A9.5 $1.27 9/30/2023645,900 shares $768,621.00 -0.1%N/A7.1 $1.19 9/15/2023646,600 shares $724,192.00 -4.7%N/A7.5 $1.12 8/31/2023678,400 shares $820,864.00 -0.5%N/A7.7 $1.21 8/15/2023681,600 shares $763,392.00 -2.5%N/A8 $1.12 7/31/2023698,700 shares $761,583.00 -11.3%N/A8.5 $1.09Warning: “DOGE Collapse” imminent (Ad)Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.Click here to see what they’re predicting now. 7/15/2023787,900 shares $961,238.00 +17.2%N/A11.2 $1.22 6/30/2023672,100 shares $937,579.50 -0.5%N/A11.5 $1.40 6/15/2023675,400 shares $1.08 million -0.3%N/A21.5 $1.60 5/31/2023677,700 shares $1.19 million -0.3%N/A23.6 $1.76 5/15/2023679,900 shares $1.23 million -2.7%N/A22 $1.81 4/30/2023698,800 shares $1.41 million +1.5%N/A19 $2.02 4/15/2023688,600 shares $1.36 million -0.2%N/A16.8 $1.97 3/31/2023690,100 shares $1.24 million -5.7%N/A16.5 $1.79 3/15/2023731,600 shares $1.51 million -0.4%N/A16 $2.07 2/28/2023734,500 shares $1.47 million -3.0%N/A15.7 $2.00 2/15/2023757,400 shares $1.70 million +3.8%N/A16 $2.25 1/31/2023729,800 shares $1.16 million -3.8%N/A16.1 $1.59 1/15/2023758,400 shares $1.21 million -3.9%N/A18.8 $1.59 12/30/2022789,400 shares $1.09 million -5.2%N/A20 $1.38 12/15/2022832,400 shares $1.27 million -3.5%N/A23.6 $1.53 11/30/2022862,200 shares $1.69 million -0.6%N/A21.1 $1.96 11/15/2022867,500 shares $1.87 million -0.5%N/A11 $2.16 10/31/2022871,500 shares $1.86 million -1.0%N/A11.3 $2.13 10/15/2022880,000 shares $1.74 million -0.7%N/A11 $1.98 9/30/2022886,000 shares $1.80 million -4.1%N/A10.7 $2.03 9/15/2022924,100 shares $1.98 million +10.2%N/A10.6 $2.14 8/31/2022838,400 shares $1.97 million -0.6%N/A9.8 $2.35 8/15/2022843,200 shares $2.16 million -3.0%N/A18.6 $2.56 7/31/2022869,600 shares $2.19 million +1.1%N/A16.8 $2.52 7/15/2022859,800 shares $1.96 million -4.3%N/A16.3 $2.28 6/30/2022898,600 shares $2.15 million -3.2%N/A13.4 $2.39 6/15/2022928,400 shares $2.38 million -4.5%N/A12.8 $2.56 5/31/2022971,700 shares $2.80 million -2.8%N/A11.9 $2.88 5/15/20221,000,000 shares $2.92 million -2.0%5.7%11.4 $2.92 4/30/20221,020,000 shares $3.01 million +2.0%5.9%10.7 $2.95 4/15/20221,000,000 shares $3.12 million +2.2%5.7%9.2 $3.12 3/31/2022978,200 shares $3.84 million +5.3%5.6%8.7 $3.93 3/15/2022928,800 shares $2.50 million -4.5%5.3%8.5 $2.69 2/28/2022972,900 shares $2.84 million -2.7%5.6%9.2 $2.92 2/15/20221,000,000 shares $3.06 million +0.9%5.7%9.4 $3.06 1/31/2022991,500 shares $2.54 million -9.0%5.7%9 $2.56 1/15/20221,090,000 shares $4.43 million +0.9%6.3%10 $4.06 12/31/20211,080,000 shares $4.20 million -1.8%6.2%11.1 $3.89 12/15/20211,100,000 shares $4.55 million +5.8%6.3%11.1 $4.14 11/30/20211,040,000 shares $4.13 million +4.0%6.0%9.9 $3.97 11/15/20211,000,000 shares $4.48 million -3.9%5.7%8.4 $4.48 10/29/20211,040,000 shares $4.46 million -4.6%N/A8.2 $4.29 10/15/20211,090,000 shares $4.98 million -3.5%N/A7 $4.57 9/30/20211,130,000 shares $5.18 million -8.1%N/A6.2 $4.58 9/15/20211,230,000 shares $6.14 million -2.4%N/A6.1 $4.99 8/31/20211,260,000 shares $6.25 million +10.5%N/A5.2 $4.96 8/13/20211,140,000 shares $5.38 million -2.6%N/A2.6 $4.72 7/30/20211,170,000 shares $6.46 million +17.4%N/A2.6 $5.52 7/15/2021996,400 shares $4.80 million +2.5%N/A2.3 $4.82 6/30/2021972,400 shares $4.75 million +4.6%N/A2.1 $4.88Warning: “DOGE Collapse” imminent (Ad)Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.Click here to see what they’re predicting now. 6/15/2021929,500 shares $4.86 million +70.7%N/A1.9 $5.23 5/28/2021544,600 shares $2.97 million +54.2%N/A1.2 $5.46 5/14/2021353,200 shares $1.36 million +15.6%N/A1 $3.86 4/30/2021305,500 shares $1.31 million +26.7%N/A0.5 $4.29 4/15/2021241,200 shares $979,272.00 -0.7%N/A0.3 $4.06 3/31/2021243,000 shares $991,440.00 +25.7%N/A0.3 $4.08 3/15/2021193,400 shares $937,990.00 -38.4%N/A0.2 $4.85 2/26/2021314,100 shares $1.52 million -11.1%N/A0.4 $4.85 2/12/2021353,100 shares $2.06 million +90.2%N/A0.4 $5.84 1/29/2021185,700 shares $768,798.00 +82.6%N/A0.3 $4.14 1/15/2021101,700 shares $441,378.00 No ChangeN/A0.2 $4.34 11/30/202013,300 shares $56,126.00 -69.8%N/A0 $4.22 11/15/202044,000 shares $182,600.00 -7.2%N/A0.1 $4.15 10/30/202047,400 shares $203,346.00 -74.2%N/A0 $4.29 10/15/2020183,700 shares $791,747.00 -33.7%N/A0 $4.31 9/30/2020277,100 shares $1.22 million -31.1%N/A0 $4.41 9/15/2020402,000 shares $1.74 million -37.5%N/A0 $4.34 8/31/2020643,400 shares $2.79 million -83.2%N/A0 $4.34 8/14/20203,820,000 shares $20.15 million -72.3%N/A0.1 $5.27 7/31/202013,770,000 shares $110.53 million -3.5%N/A0.4 $8.03 7/15/202014,270,000 shares $103.46 million +118.9%N/A0.4 $7.25 6/30/20206,520,000 shares $72.37 million +37.0%N/A0.2 $11.10 6/15/20204,760,000 shares $22.51 million -29.5%N/A0.2 $4.73 5/29/20206,750,000 shares $31.79 million +163.7%N/A0.5 $4.71 5/15/20202,560,000 shares $12.57 million +806.5%N/A0.2 $4.91 4/30/2020282,400 shares $946,040.00 -54.8%N/A0 $3.35 4/15/2020625,200 shares $2.19 million +73.5%N/A0.3 $3.50 3/31/2020360,300 shares $1.10 million -61.2%N/A0.3 $3.06 PPBT Short Interest - Frequently Asked Questions What is Purple Biotech's current short interest? Short interest is the volume of Purple Biotech shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 51,100 shares of PPBT short. 1.94% of Purple Biotech's shares are currently sold short. Learn More on Purple Biotech's current short interest. What is a good short interest ratio for Purple Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPBT shares currently have a short interest ratio of 1.0. Learn More on Purple Biotech's short interest ratio. Which institutional investors are shorting Purple Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Purple Biotech: Group One Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Purple Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.94% of Purple Biotech's floating shares are currently sold short. Is Purple Biotech's short interest increasing or decreasing? Purple Biotech saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 51,100 shares, an increase of 5.6% from the previous total of 48,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Purple Biotech's float size? Purple Biotech currently has issued a total of 1,331,000 shares. Some of Purple Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Purple Biotech currently has a public float of 2,630,000 shares. How does Purple Biotech's short interest compare to its competitors? 1.94% of Purple Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Purple Biotech: Incannex Healthcare Inc. (0.36%), Affimed (4.63%), Marker Therapeutics, Inc. (4.99%), Spruce Biosciences, Inc. (0.71%), HCW Biologics Inc. (1.70%), Citius Pharmaceuticals, Inc. (6.39%), Athira Pharma, Inc. (2.91%), GeoVax Labs, Inc. (6.86%), ImmunoPrecise Antibodies Ltd. (14.01%), Biomerica, Inc. (0.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Purple Biotech stock? Short selling PPBT is an investing strategy that aims to generate trading profit from Purple Biotech as its price is falling. PPBT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Purple Biotech? A short squeeze for Purple Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPBT, which in turn drives the price of the stock up even further. How often is Purple Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPBT, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Incannex Healthcare Short Interest Data Affimed Short Interest Data Marker Therapeutics Short Interest Data Spruce Biosciences Short Interest Data HCW Biologics Short Interest Data Citius Pharmaceuticals Short Interest Data Athira Pharma Short Interest Data GeoVax Labs Short Interest Data ImmunoPrecise Antibodies Short Interest Data Biomerica Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPBT) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PPBT Stock Free PPBT Stock Alerts